Register for email alerts and news feeds:
This journal | BMJ Group
rss
Evidence-Based Medicine 2007;12:9; doi:10.1136/ebm.12.1.9
Copyright © 2007 by the BMJ Publishing Group Ltd.

Therapeutics

Budesonide-formoterol for maintenance and as needed reliever treatment reduced asthma exacerbations

Rabe KF, Atienza T, Magyar P, et al. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 2006;368:744–53.[CrossRef][Medline]

Q In patients with asthma receiving budesonide-formoterol (B-F) for maintenance treatment, how does B-F as needed reliever treatment compare with as needed formoterol and as needed terbutaline for reducing exacerbations?

Clinical impact ratings GP/FP/Primary care ******{star} Paediatrics ******{star} Respirology *****{star}{star}

Key Words: asthma • budesonide • ethanolamines • terbutaline

The first 150 words of the full text of this article appear below.

METHODS

Formula Design: randomised controlled trial.

Formula Allocation: concealed.*

Formula Blinding: blinded (patients and healthcare providers).*

Formula Follow up period: 12 months.

Formula Setting: 289 centres in 20 countries.

Formula Patients: 3394 patients >=12 years of age (mean age 42 y, 60% women) who had >1 severe asthma exacerbation in the past 12 months, had used inhaled corticosteroids (ICS) for >=3 months, and had an FEV1 of 50–100% of predicted normal with >=12% reversibility after inhalation of terbutaline, 1 mg. Exclusion criteria included respiratory infection affecting asthma and use of oral corticosteroids within 1 month of study entry.

Formula Intervention: as needed treatment with B-F, 160/4.5 µg (n = 1113); formoterol, 4.5 µg (n = 1140); or terbutaline, 0.4 mg (n = 1141). Patients were instructed to use their reliever medication <=10 inhalations per day. All patients received B-F, 160/4.5 µg, 1 inhalation twice daily for maintenance treatment.

Formula Outcomes: first severe exacerbation (emergency department [ED] visit or hospital . . . [Full text of this article]

Magdie L Kohn, MD, FRCPC

Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Other articles noted
Evid. Based Med. 2007 12: 31-32. (in ) [Extract] [Full Text] [PDF]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.